GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) » Definitions » Research & Development

Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Research & Development : RM0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Y.S.P. Southeast Asia Holding Bhd Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Y.S.P. Southeast Asia Holding Bhd's Research & Development for the three months ended in Dec. 2024 was RM0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was RM0.0 Mil.


Y.S.P. Southeast Asia Holding Bhd Research & Development Historical Data

The historical data trend for Y.S.P. Southeast Asia Holding Bhd's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y.S.P. Southeast Asia Holding Bhd Research & Development Chart

Y.S.P. Southeast Asia Holding Bhd Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Y.S.P. Southeast Asia Holding Bhd Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Y.S.P. Southeast Asia Holding Bhd Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Y.S.P. Southeast Asia Holding Bhd  (XKLS:7178) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Y.S.P. Southeast Asia Holding Bhd Research & Development Related Terms

Thank you for viewing the detailed overview of Y.S.P. Southeast Asia Holding Bhd's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Y.S.P. Southeast Asia Holding Bhd Business Description

Traded in Other Exchanges
N/A
Address
Number 1, Jalan Wan Kadir, Level 22, Menara LGB, Taman Tun Dr. Ismail, Kuala Lumpur, MYS, 60000
Y.S.P. Southeast Asia Holding Bhd is an investment company, that engages in the pharmaceutical business, and provision of management services. It operates through the following segments: Trading, Manufacturing, and Investment Holding. The Trading segment imports, exports, and trades various kinds of pharmaceutical products, and traditional herbal and veterinary products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. The firm's majority of revenue comes from the Manufacturing segment. The majority of revenue is concentrated in Malaysia.

Y.S.P. Southeast Asia Holding Bhd Headlines

No Headlines